The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ALIMERA SCIENCES INC | Common | 016259103 | 6,106 | 6,241,581 | SH | SOLE | 6,241,581 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | Common | 02043Q107 | 68,953 | 700,100 | SH | SOLE | 700,100 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | Common | 03152W109 | 146,346 | 9,369,150 | SH | SOLE | 9,369,150 | 0 | 0 | ||
ARGENX SE | Sponsored ADR | 04016X101 | 64,801 | 782,053 | SH | SOLE | 782,053 | 0 | 0 | ||
ARROWHEAD PHARMACEUTICALS INC | Common | 04280A100 | 6,120 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
ASCENDIS PHARMA | Sponsored ADR | 04351P101 | 137,253 | 2,063,336 | SH | SOLE | 2,063,336 | 0 | 0 | ||
ASSEMBLY BIOSCIENCES INC | Common | 045396108 | 37,776 | 963,427 | SH | SOLE | 963,427 | 0 | 0 | ||
AVROBIO INC | Common | 05455M100 | 2,856 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
BIODELIVERY SCIENCES INTL | Common | 09060J106 | 16,041 | 5,437,779 | SH | SOLE | 5,437,779 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | Common | 09061G101 | 152,865 | 1,622,770 | SH | SOLE | 1,622,770 | 0 | 0 | ||
CATALYST PHARMACEUTICALS INC | Common | 14888U101 | 14,031 | 4,497,042 | SH | SOLE | 4,497,042 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | Common | 189464100 | 52,128 | 1,146,436 | SH | SOLE | 1,146,436 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | Common | 23257D103 | 17,209 | 1,282,374 | SH | SOLE | 1,282,374 | 0 | 0 | ||
DERMIRA INC | Common | 24983L104 | 16,945 | 1,841,823 | SH | SOLE | 1,841,823 | 0 | 0 | ||
ENDOCYTE INC | Common | 29269A102 | 78,594 | 5,695,200 | SH | SOLE | 5,695,200 | 0 | 0 | ||
FENNEC PHARMACEUTICALS INC | Common | 31447P100 | 10,700 | 1,022,666 | SH | SOLE | 1,022,666 | 0 | 0 | ||
GLOBAL BLOOD THERAPEUTICS INC | Common | 37890U108 | 31,665 | 700,548 | SH | SOLE | 700,548 | 0 | 0 | ||
HORIZON PHARMA PLC | Common | G4617B105 | 92,631 | 5,593,683 | SH | SOLE | 5,593,683 | 0 | 0 | ||
IMMUNOMEDICS INC | Common | 452907108 | 419,301 | 17,714,461 | SH | SOLE | 17,714,461 | 0 | 0 | ||
INTEC PHARMA LTD | Common | M53644106 | 11,311 | 2,570,705 | SH | SOLE | 2,570,705 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | Common | 462260100 | 104,675 | 8,177,720 | SH | SOLE | 8,177,720 | 0 | 0 | ||
MADRIGAL PHARMACEUTICALS INC | Common | 558868105 | 136,918 | 489,536 | SH | SOLE | 489,536 | 0 | 0 | ||
MEDICINES CO | Common | 584688105 | 35,290 | 961,574 | SH | SOLE | 961,574 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | Common | 60468T105 | 236,546 | 4,798,101 | SH | SOLE | 4,798,101 | 0 | 0 | ||
ONCOBIOLOGICS INC | Common | 68235M105 | 578 | 683,531 | SH | SOLE | 683,531 | 0 | 0 | ||
ONCOBIOLOGICS INC - WARRANT A | Warrant | 68235M113 | 12 | 233,333 | SH | SOLE | 233,333 | 0 | 0 | ||
ONCOSEC MEDICAL INC | Common | 68234L207 | 5,531 | 4,007,696 | SH | SOLE | 4,007,696 | 0 | 0 | ||
PACIRA PHARMACEUTICALS INC | Common | 695127100 | 46,813 | 1,460,610 | SH | SOLE | 1,460,610 | 0 | 0 | ||
PERNIX THERAPEUTICS HOLDINGS INC | Convertible Debt | 71426VAK4 | 2,618 | 6,000,000 | PRN | SOLE | 6,000,000 | 0 | 0 | ||
PTC THERAPEUTICS INC | Common | 69366J200 | 77,406 | 2,294,877 | SH | SOLE | 2,294,877 | 0 | 0 | ||
PUMA BIOTECHNOLOGY INC | Common | 74587V107 | 61,183 | 1,034,375 | SH | SOLE | 1,034,375 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | Common | 803607100 | 126,751 | 958,928 | SH | SOLE | 958,928 | 0 | 0 | ||
SESEN BIO INC | Common | 817763105 | 13,260 | 6,800,000 | SH | SOLE | 6,800,000 | 0 | 0 | ||
SPECTRUM PHARMACEUTICALS INC | Common | 84763A108 | 71,679 | 3,419,818 | SH | SOLE | 3,419,818 | 0 | 0 | ||
TELIGENT INC | Common | 87960W104 | 18,336 | 5,299,431 | SH | SOLE | 5,299,431 | 0 | 0 | ||
TG THERAPEUTICS INC | Common | 88322Q108 | 65,093 | 4,950,031 | SH | SOLE | 4,950,031 | 0 | 0 | ||
TRICIDA INC | Common | 89610F101 | 32,763 | 1,095,764 | SH | SOLE | 1,095,764 | 0 | 0 | ||
VANDA PHARMACEUTICALS INC | Common | 921659108 | 53,344 | 2,800,191 | SH | SOLE | 2,800,191 | 0 | 0 | ||
VIKING THERAPEUTICS INC | Common | 92686J106 | 42,433 | 4,471,300 | SH | SOLE | 4,471,300 | 0 | 0 | ||
SPDR SERIES TRUST - S&P BIOTECH | ETF | 78464A870 | 1,875 | 750,000 | SH | Put | SOLE | 750,000 | 0 | 0 | |
SPDR SERIES TRUST - S&P BIOTECH | ETF | 78464A870 | 1,575 | 500,000 | SH | Put | SOLE | 500,000 | 0 | 0 | |
SPDR SERIES TRUST - S&P BIOTECH | ETF | 78464A870 | 1,850 | 500,000 | SH | Put | SOLE | 500,000 | 0 | 0 | |
XENON PHARMACEUTICALS INC | Common | 98420N105 | 11,059 | 1,202,118 | SH | SOLE | 1,202,118 | 0 | 0 | ||
ZOGENIX INC | Common | 98978L204 | 66,446 | 1,503,313 | SH | SOLE | 1,503,313 | 0 | 0 |